Investigators with Dermatology Associates, St. Luke's-Roosevelt Hospital, N.Y., conducted two 8-week, multi-center, randomized, investigator-blind studies to compare the efficacy and safety of a hydrophilic cream formulation containing tretinoin 0.05 percent, hydroquinne 4.0 percent and fluocinolone acetonide 0.01 percent (RA+HQ+FA) with the dual-combination agents tretinoin hydroquinone, tretinoin plus fluocinolone acetonide, and hydroquinone plus fluocinolone acetonide.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.